{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:03:06Z","timestamp":1792605786651,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jhep.2019.05.033","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T23:38:19Z","timestamp":1560901099000},"page":"699-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care"],"prefix":"10.1016","volume":"71","author":[{"given":"John F.","family":"Dillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8810-2295","authenticated-orcid":false,"given":"Emma M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hapca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rezaeihemami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Weatherburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2019.05.033_b0005","article-title":"Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)","volume":"13","author":"Donnan","year":"2009","journal-title":"Health Technol Assess [Internet]"},{"key":"10.1016\/j.jhep.2019.05.033_b0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2011.03.020","article-title":"Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort","volume":"56","author":"Armstrong","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.033_b0015","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.3399\/bjgp17X689365","article-title":"Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups","volume":"67","author":"Homer","year":"2017","journal-title":"Br J Gen Pract"},{"issue":"8","key":"10.1016\/j.jhep.2019.05.033_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5498\/wjp.v8.i1.27","article-title":"Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland","volume":"16","author":"Gnanavel","year":"2018","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.jhep.2019.05.033_b0025","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ejhf.532","article-title":"Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study","volume":"18","author":"Jan","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhep.2019.05.033_b0030","doi-asserted-by":"crossref","DOI":"10.1136\/flgastro-2017-100909","article-title":"Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the \u2018intelligent LFT\u2019 pathway for the automated assessment of deranged liver enzymes","volume":"9","author":"Miller","year":"2018","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.033_b0035","article-title":"A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes","volume":"2","author":"Radcke","year":"2015","journal-title":"Eur J Gastroenterol Hepatol [Internet]"},{"key":"10.1016\/j.jhep.2019.05.033_b0040","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients. (Review Article)","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2019.05.033_b0045","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2019.05.033_b0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Stefano","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.jhep.2019.05.033_b0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1574887111666160810101202","article-title":"Epidemiology and natural history of alcoholic liver disease","volume":"11","author":"Masarone","year":"2016","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.jhep.2019.05.033_b0060","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.033_b0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2019.05.033_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162980","article-title":"The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991\u20132011","volume":"11","author":"Bouttell","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.05.033_b0075","series-title":"Diseases of the gastrointestinal tract and liver","first-page":"735","author":"Shearman","year":"1997"},{"key":"10.1016\/j.jhep.2019.05.033_b0080","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jhep.2019.05.033_b0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1099-1557(199907)8:4<275::AID-PDS427>3.0.CO;2-D","article-title":"Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts","volume":"8","author":"Duh","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.jhep.2019.05.033_b0090","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study","volume":"328","author":"Kim","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2019.05.033_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2296-12-9","article-title":"Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort","volume":"12","author":"Arnold","year":"2011","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jhep.2019.05.033_b0100","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.1840200611","article-title":"Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study","volume":"20","author":"Stefano","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2019.05.033_b0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1532-0464(02)00526-9","article-title":"The epidemiology of liver disease in Tayside database: a population-based record-linkage study","volume":"35","author":"Steinke","year":"2002","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jhep.2019.05.033_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-7-54","article-title":"Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03\/38\/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)","volume":"7","author":"Donnan","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jhep.2019.05.033_b0115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bmj.322.7281.276","article-title":"How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact","volume":"322","author":"Sherwood","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2019.05.033_b0120","doi-asserted-by":"crossref","unstructured":"Jansky M, Mattlinger C, Nguyen-Tat M, Galle PR, Lammert F, J\u00e4ger J, et al. Abkl\u00e4rung von Leberwerterh\u00f6hungen in der haus\u00e4rztlichen Praxis \u2013 Versorgungsrealit\u00e4t in Deutschland. Dtsch Med Wochenschr (EFirst), 2018.","DOI":"10.1055\/s-0043-122251"},{"key":"10.1016\/j.jhep.2019.05.033_b0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2017-314924","article-title":"Guidelines on the management of abnormal liver blood tests","volume":"67","author":"Newsome","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.033_b0130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.2009.203166","article-title":"Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease","volume":"59","author":"Parkes","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2019.05.033_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-12-2","article-title":"Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population","volume":"12","author":"Sumida","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.033_b0140","unstructured":"European Association for the Study of the Liver. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis [Internet]. 2015 [cited 2018 Jun 26]. Available from: http:\/\/www.easl.eu\/medias\/cpg\/Non-invasive\/English-report.pdf."},{"key":"10.1016\/j.jhep.2019.05.033_b0145","unstructured":"National Institute for Health and Clinical Excellence. Weight management: lifestyle services for overweight or obese adults [Internet]. 2014 [cited 2018 Jun 21]. Available from: https:\/\/www.nice.org.uk\/guidance\/ph53\/chapter\/4-Considerations#cost-effectiveness."},{"key":"10.1016\/j.jhep.2019.05.033_b0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","article-title":"Design and analysis of stepped wedge cluster randomized trials","volume":"28","author":"Hussey","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jhep.2019.05.033_b0155","unstructured":"Curtis L, Burns A. Unit Costs of Health & Social Care 2016 [Internet]. Personal Social Services Research Unit, University of Kent; 2016 [cited 2018 Jun 21]. Available from: https:\/\/www.pssru.ac.uk\/pub\/uc\/uc2016\/full.pdf."},{"key":"10.1016\/j.jhep.2019.05.033_b0160","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal 2013 [Internet]. 2013 [cited 2018 Jun 21]. Available from: https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/Foreword."},{"key":"10.1016\/j.jhep.2019.05.033_b0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"issue":"112","key":"10.1016\/j.jhep.2019.05.033_b0170","first-page":"18","article-title":"ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries","volume":"20","author":"Kwo","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2019.05.033_b0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.39308.560069.BE","article-title":"NICE\u2019s cost effectiveness threshold","volume":"335","author":"Appleby","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2019.05.033_b0180","article-title":"The Performance of Enhanced Liver Fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jhep.2019.05.033_b0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2016.09.017","article-title":"Extensive testing or focused testing of patients with elevated liver enzymes","volume":"66","author":"Tapper","year":"2017","journal-title":"J Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781930354X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781930354X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:36:40Z","timestamp":1759174600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781930354X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S016882781930354X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2019.05.033","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2019.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}